Reinhart Partners LLC. Purchases 360,365 Shares of Maximus, Inc. (NYSE:MMS)

Reinhart Partners LLC. raised its position in Maximus, Inc. (NYSE:MMS - Free Report) by 65.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 911,511 shares of the health services provider's stock after buying an additional 360,365 shares during the quarter. Maximus comprises about 2.3% of Reinhart Partners LLC.'s holdings, making the stock its 21st largest position. Reinhart Partners LLC. owned about 1.61% of Maximus worth $62,156,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in the company. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.9% in the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares in the last quarter. IFP Advisors Inc grew its position in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after purchasing an additional 428 shares in the last quarter. NBC Securities Inc. grew its position in shares of Maximus by 114,900.0% in the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after purchasing an additional 1,149 shares in the last quarter. Finally, Allworth Financial LP grew its position in shares of Maximus by 1,638.4% in the fourth quarter. Allworth Financial LP now owns 1,495 shares of the health services provider's stock valued at $116,000 after purchasing an additional 1,409 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Price Performance

Shares of NYSE MMS opened at $70.81 on Friday. The stock has a market cap of $3.99 billion, a PE ratio of 15.23 and a beta of 0.62. Maximus, Inc. has a fifty-two week low of $63.77 and a fifty-two week high of $93.97. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock has a fifty day moving average of $70.23 and a 200-day moving average of $71.32.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the previous year, the business earned $1.57 earnings per share. The firm's revenue was up 1.0% on a year-over-year basis. Equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, May 31st. Investors of record on Thursday, May 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.69%. The ex-dividend date of this dividend was Thursday, May 15th. Maximus's payout ratio is 23.86%.

Insider Buying and Selling

In related news, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director now directly owns 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Separately, Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.